News | PET-CT | September 13, 2017

Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017

Trial assessed the impact of F-18 PET/CT on patient management in biochemically recurrent prostate cancer patients scheduled for salvage treatment with curative intent

Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017

September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALCON clinical trial of fluciclovine (18F) positron emission tomography/computed tomography (PET/CT) at the 2017 American Society for Radiation Oncology (ASTRO) annual meeting Sept. 24-27 in San Diego. The FALCON trial evaluated the impact of F-18 PET/CT on patient management in biochemically recurrent prostate cancer patients scheduled for salvage radiation therapy treatment with curative intent. Trial results will be presented by Eugene Teoh, M.D., Oxford University Hospitals NHS Trust, Oxford, U.K.

Blue Earth Diagnostics is also hosting an Industry-Expert Theater event, “A Novel Option for Biochemically Recurrent Prostate Cancer Localization,” with invited speaker Abhishek Solanki, M.D., assistant professor of radiation oncology, Loyola University School of Medicine, Chicago, which will be held on Tuesday, Sept. 26.

For more information: www.blueearthdiagnostics.com

Related Content

Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
IBA Dosimetry Launches SmartScan Automated and Guided Beam Commissioning Solution
Technology | Quality Assurance (QA) | July 27, 2018
IBA (Ion Beam Applications S.A.) announced the market launch of its new SmartScan solution at the 60th annual American...
Overlay Init